Shift Bioscience

Shift Bioscience publishes improved metric calibration framework for robust genetic perturbation modeling using AI Virtual Cells

Cambridge, UK, 11 November 2025: Shift Bioscience (Shift), a biotechnology company uncovering the biology of cell rejuvenation to end the morbidity and mortality of aging, today announced the release of new research detailing an improved framework for evaluating benchmark metric calibration in virtual cell models1. Using well-calibrated metrics, the study demonstrates that virtual cell models...

Shift Bioscience establishes North American facilities to expand capabilities of AI-powered virtual cell technology

Head of Machine Learning, Lucas Camillo, to lead team with Professor Bo Wang, University of Toronto, appointed as Senior Advisor Expansion into global AI hub to accelerate growth of IP portfolio and progress toward key technical milestones 18 February 2025 – Cambridge, UK, and Toronto, Canada – Shift Bioscience, a biotech company using an AI...
Shift Bioscience Ltd The Gurdon Institute Tennis Court Road Cambridge CB2 1QN United Kingdom